Viewing Study NCT03772561


Ignite Creation Date: 2025-12-24 @ 12:09 PM
Ignite Modification Date: 2026-01-28 @ 9:00 AM
Study NCT ID: NCT03772561
Status: RECRUITING
Last Update Posted: 2025-07-22
First Post: 2018-12-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of AZD5363 + Olaparib + Durvalumab in Patients With Advanced or Metastatic Solid Tumor Malignancies
Sponsor: National University Hospital, Singapore
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module